CA
NZ
UK
AU
IND
US
Consumer behaviour heading into Prime Day is expected to show a pronounced shift toward value-seeking, with participation concentrated in household staples and electronics rather than the discretionary upgrades that drove higher transaction values in prior years. The energy-driven inflation and rising borrowing costs under …
Oruka Therapeutics, Inc. (NASDAQ:ORKA) advanced sharply as investors reassessed the value of differentiated psoriasis assets following a major sector transaction.
The Breakthrough Therapy Designation accelerates the regulatory review pathway and entitles Praxis to more intensive FDA guidance during development. SCN2A-DEE represents a high unmet need population where current standard-of-care options provide limited seizure control, making the designation strategically significant for the programme and for …
The investment reflects UPS's strategic pivot toward higher-margin specialised healthcare logistics at a time when parcel volume growth in the broader e-commerce segment has moderated. GLP-1 therapies have generated unprecedented prescription volumes over the past two years, creating structural demand for pharmaceutical cold chain …
Definium Therapeutics, Inc. (NASDAQ:DFTX), formerly Mind Medicine, closed sharply higher after reporting positive topline results from the Phase 3 Emerge study of DT120 in adults with major depressive disorder.
A Post-IPO Correction Turns Into a Rout
The upgrade reversed a prolonged period of negative sentiment around the company stemming from accounting and governance concerns, with the research note noting that the operational pipeline for AI server deployments provides significantly greater revenue visibility than prior guidance suggested. Super Micro's shares had …
The departure follows a string of high-profile exits from Google's AI division and arrives as Alphabet is already contending with a structural shift in search behaviour driven by AI-native competitors. The stock's 5.32% decline in a single session reflects both the severity of the …
Horizon Quantum Holdings Ltd. (NASDAQ:HQ) climbed nearly 20% as investors responded to an agreement involving the deployment of a 256-qubit trapped-ion system from IonQ at the company’s European headquarters in Dublin.
The rally has been reinforced by a landmark AI infrastructure supply agreement with Anthropic signed Monday, which provides contractual forward revenue visibility in the high-bandwidth memory segment central to AI accelerator performance. At least one major research desk has raised its price target to …
Please wait processing your request...